This bill, known as the Pennsylvania Common Cents Act, requires government agencies, municipalities, and public utilities to round cash payments to the nearest five-cent increment when collecting face-to-face sales. Specifically, totals ending in one, two, six, or seven cents will be rounded down, while those ending in three, four, eight, or nine cents will be rounded up. The rule applies only to physical cash transactions and does not affect payments made by card, check, or other digital methods. It takes effect immediately upon passage.
This bill modifies how Pennsylvania distributes fees collected from unconventional gas wells, specifically directing 25% of those funds to a state account for bridge improvements. The legislation allows counties and municipalities to use these monies to repair or upgrade bridges regardless of whether they qualify for federal funding assistance. Additionally, it permits larger counties to allocate these funds toward improving bridges owned by public transportation authorities. The changes take effect 60 days after the bill becomes law.
This bill removes outdated Pennsylvania laws regarding insurance that are no longer in effect. It specifically repeals the Flood Insurance Education and Information Act of 1996 and certain sections of the Insurance Company Law of 1921. The changes take effect immediately upon passage, streamlining the state's insurance code by eliminating expired provisions.
HB 2207 increases the maximum loan amount for small businesses in Pennsylvania seeking capital development loans (for land, buildings, machinery, and equipment) from $400,000 to $2,000,000, or 50% of total project costs, whichever is lower. It clarifies that costs incurred during the 12 months before applying are included in the total project costs calculation. The bill directly affects small businesses applying for these state-backed loans through Pennsylvania's capital development program. The changes take effect 60 days after enactment.
HB 2234 creates a tax credit for Pennsylvania breweries that donate spent grain byproduct (leftover grain from brewing) to local farms. Breweries can claim a credit of $0.16 per pound of dry weight donated, up to $30,000 annually or their total tax liability, if the grain is delivered to farms within 100 miles. The credit applies to donations made to "eligible agricultural operations" engaged in normal farming activities under Pennsylvania law. Applications must be submitted by February 1 each year for the prior year's donations, with the Department of Revenue reviewing eligibility and coordinating with the Liquor Control Board. This directly benefits breweries and farms participating in the program by reducing brewery tax bills while repurposing brewing waste.
HB 2162 amends Pennsylvania's Wholesale Prescription Drug Distributors License Act to clarify definitions and license application requirements. It specifically defines "virtual manufacturer" as a business that doesn't physically handle drugs in Pennsylvania but has FDA approval processes underway, including submitting or planning to submit FDA applications within 12 months. The bill adds new application requirements: manufacturers of unapproved drugs must state they've applied to or plan to apply to the FDA within 12 months, and virtual manufacturers must provide similar documentation. Crucially, it states the state department cannot require FDA approval as a condition for licensure. This directly affects drug distributors operating under the "virtual manufacturer" model and unapproved drug manufacturers seeking state licenses.
HB 75 amends Pennsylvania's Osteopathic Medical Practice Act to update the definition of "primary supervising physician" to include medical doctors (MDs) licensed by the State Board of Medicine, alongside osteopathic physicians (DOs). This change allows physician assistants to have either an MD or a DO as their primary supervising physician under a written agreement, expanding oversight options beyond current restrictions. The amendment takes effect 60 days after enactment and does not alter other provisions of the law.
HB 76 amends Pennsylvania's Medical Practice Act of 1985 to update two key definitions: it revises the term "doctor of osteopathy" to reference the State Board of Osteopathic Medicine (replacing outdated language) and clarifies that a "primary supervising physician" for physician assistants must be licensed by either the State Board of Medicine or the State Board of Osteopathic Medicine. This change directly affects osteopathic doctors, physician assistants, and the licensing boards by aligning the law with current regulatory structures. The bill makes no substantive changes to medical practice rules but ensures definitions accurately reflect the oversight bodies responsible for licensing. It takes effect 60 days after enactment.
HB 1127 authorizes Pennsylvania to join the Dentist and Dental Hygienist Compact, enabling dentists and dental hygienists licensed in Pennsylvania to practice in other participating states without obtaining separate licenses. The bill establishes a "Compact Privilege" that allows qualified professionals to practice across state lines while maintaining each state's regulatory authority over scope of practice and disciplinary actions. Key mechanisms include streamlined licensure pathways, shared disciplinary information between states, and protection of public health standards. This affects licensed dental professionals seeking to work in multiple compact states, particularly addressing workforce mobility and access to care.
HB 69 amends Pennsylvania's Cancer Drug Repository Program to allow unused, unopened cancer prescription drugs to be redistributed to indigent patients through approved pharmacies. The bill updates definitions (e.g., clarifying "cancer drug" includes drugs treating cancer or its side effects), requires drugs to be in original sealed packaging with unexpired dates, and mandates the State Board of Pharmacy to maintain a list of approved participating pharmacies. It also adds requirements for annual reporting and establishes procedures for restocking and dispensing drugs while maintaining safety standards. This directly affects indigent cancer patients seeking affordable medication and pharmacies participating in the program.
SB 535 amends Pennsylvania's Osteopathic Medical Practice Act to clarify the role of genetic counselors. It adds a definition for "genetic test" (including DNA/RNA analysis and chromosome studies) and specifies that genetic counselors may order such tests, provide documentation, and coordinate care - but cannot diagnose, test, manage, or treat genetic conditions. The bill directly affects genetic counselors practicing within Pennsylvania's osteopathic medical framework. These changes aim to standardize terminology and practice boundaries without altering the scope of other medical professionals.
This bill amends Pennsylvania's Medical Practice Act to clarify the role of genetic counselors. It adds a definition for "genetic test" (covering DNA/RNA analysis, biochemical tests, and chromosome studies) and specifies that genetic counselors may order these tests, coordinate care, and document medical information for clients' records. Crucially, the bill explicitly states genetic counselors cannot diagnose, test for, manage, or treat genetic conditions. The changes directly affect licensed genetic counselors practicing in Pennsylvania, defining their scope within the state's medical licensing framework. The bill takes effect 60 days after enactment.